Latest

neurodegenerative diseases

The image shows the tau proteins associated with Alzheimer's disease.

·June 19, 2013·3 min read

New Alzheimer’s Research Suggests Possible Cause: The Interaction of Proteins in the Brain

Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.

Featured Neurology

·June 19, 2013·2 min read

Antioxidant Shows Promise in Parkinson’s Disease

Researchers discover Diapocynin, a synthetic molecule derived from apocynin, protects neurobehavioural function in transgenic mice with Parkinson's disease symptoms. The molecule helps prevent deficits in motor coordination.

Electrophysiology Featured

·June 19, 2013·2 min read

What Do Memories Look Like?

Researchers engineered microscopic probes which light up synapses in living neurons by attaching fluorescent markers onto synaptic proteins without affecting the neuron's ability to function.

This is a diagram of the brain and central nervous system.

Featured Neurology

·June 19, 2013·3 min read

Staging System in ALS Shows Potential Tracks of Disease Progression

Performing post-mortem staging of the brains and spinal cord tissue of patients with ALS, researchers discover the neurodegenerative disease could progress from one start point in the CNS to other regions of the brain and spinal cord.

The image shows an electrophysiology slide of neurons in this alzheimer's research.

Featured Neurology

·June 17, 2013·2 min read

Blocking Overactive Receptor in Alzheimer’s Recovers Memory Loss and More

Researchers show memory pathology in older mice can be reversed by blocking the activity of a specific receptor in the brain. Blocking the B1R receptor helps recover memory and cerebrovascular function.

The image is a photomicrograph of the nerve cell. The caption best describes the image.

Featured Neurology

·June 17, 2013·4 min read

Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer’s

Researchers have developed an experimental drug, NitroMemantine, to boost brain synapses lost in Alzheimer's disease. The drug stops the destructive cascade of brain changes which destroy connections between neurons that leads to memory loss and cognitive decline.

Featured Neurology

·June 17, 2013·3 min read

Artificial Sweetener a Potential Treatment for Parkinson’s Disease

Researchers have discovered Mannitol, a sugar alcohol commonly found in sugar-free gum and candy, prevents clumps of the protein α-synuclein from building in the brain. This build of this protein is characteristic of Parkinson's disease. The finding could provide potential treatment options for this and other neurodegenerative diseases.

The image shows a dna double helix in a man's head.

Featured Genetics

·June 17, 2013·4 min read

Rare Genomic Mutations Found in Ten Families with Early-Onset, Familial Alzheimer’s Disease

A new study uncovers unique changes in DNA structure in genes important to neuronal function in relatives with early onset, familial Alzheimer's disease.

The image shows microtubule disintegration in alzheimer's disease.

Featured Neurology Open Neuroscience Articles

·June 13, 2013·3 min read

A Peptide to Protect Brain Function

Researchers develop a protein called NAP which protects and restores nerve cell communication in some neurodegenerative diseases.

The diagram shows beta amyloid formation in alzheimer's disease.

Featured Neurology

·June 12, 2013·4 min read

Alzheimer’s Brain Change Measured in Humans

Researchers have successfully measured a significant difference between the brains of patients with an inherited form of Alzheimer's disease and their healthy family members who do not carry the genetic mutation for the disease.

The image shows the SOD1 in mice spinal cords. The caption best describes the image.

Featured Genetics Open Neuroscience Articles

·June 12, 2013·4 min read

Jammed Molecular Motors May Play Role in Development of ALS

A new study finds slowdowns in the transport and delivery of proteins, nutrients and signaling molecules within nerve cells could contribute to the development of ALS.

The image shows the activity changes in the brain during the brain machine interface study.

Featured Neuroscience

·June 11, 2013·4 min read

New Tasks Become as Simple as Waving a Hand with Brain-Computer Interfaces

Researchers show that when humans use brain-computer interface technology, the brain behaves much like it does when completing simple motor skills such as waving a hand. This technology could help improve the daily lives of those who are paralyzed or lost specific abilities due to neurodegenerative diseases.

1 … 112 113 114 115 116 … 129

neurodegenerative diseases

New Alzheimer’s Research Suggests Possible Cause: The Interaction of Proteins in the Brain

Antioxidant Shows Promise in Parkinson’s Disease

What Do Memories Look Like?

Staging System in ALS Shows Potential Tracks of Disease Progression

Blocking Overactive Receptor in Alzheimer’s Recovers Memory Loss and More

Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer’s

Artificial Sweetener a Potential Treatment for Parkinson’s Disease

Rare Genomic Mutations Found in Ten Families with Early-Onset, Familial Alzheimer’s Disease

A Peptide to Protect Brain Function

Alzheimer’s Brain Change Measured in Humans

Jammed Molecular Motors May Play Role in Development of ALS

New Tasks Become as Simple as Waving a Hand with Brain-Computer Interfaces

Looksmaxxing Trend Poses Health Risks for Young Men

How “Pink Noise” in Conversation Makes Chats Enjoyable

Can Obesity Drugs Protect the Brain?

SuperAger AI Connectome Predicts Alzheimer’s Years Early

Subscribe